Update Conference on Mantle Cell Lymphoma

Department of Oncology at HUSJR and the Institut d’Investigació Sanitària Pere Virgili (IISPV)

Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin B-cell lymphoma, accounting for approximately 5–7% of all lymphomas. It originates in a specific area of the lymph node known as the mantle zone, and typically affects older individuals, especially men.

The prognosis has improved in recent years thanks to advances in molecular diagnostics and targeted therapies, although it remains a challenging lymphoma that requires a personalized and multidisciplinary approach.

This in-person meeting will address the most relevant aspects of the diagnosis and treatment of mantle cell lymphoma, including the latest developments in molecular biology, first- and second-line therapeutic options, and the emerging role of CAR-T cell immunotherapy.

An excellent opportunity to update knowledge, share clinical experiences, and build collaborative networks in a top-level academic environment.
We look forward to welcoming you!